Cdc42EP3/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts. by Calvo, F et al.
ArticleCdc42EP3/BORG2 and Septin Network Enables
Mechano-transduction and the Emergence of
Cancer-Associated FibroblastsGraphical AbstractHighlightsd Cdc42EP3-mediated coordination of actin and septin is
required for CAF function
d The septin network is changed in CAFs and is required for
their function
d Cdc42EP3 enables responses to changes in matrix stiffness
d Upregulation of Cdc42EP3 is required for the activation of
normal fibroblastsCalvo et al., 2015, Cell Reports 13, 2699–2714
December 29, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.11.052Authors
Fernando Calvo, Romana Ranftl, Steven
Hooper, ..., Facundo Batista, Guillaume
Charras, Erik Sahai
Correspondence
fernando.calvo@icr.ac.uk (F.C.),
erik.sahai@crick.ac.uk (E.S.)
In Brief
Calvo et al. identify Cdc42EP3 as a
regulator of the pro-tumorigenic
functions of cancer-associated
fibroblasts. Cdc42EP3 is upregulated
during fibroblast activation and
coordinates actin and septin
rearrangements that are required for
mechanotransduction and CAF
functions.
Cell Reports
ArticleCdc42EP3/BORG2 and Septin Network
Enables Mechano-transduction
and the Emergence of Cancer-Associated Fibroblasts
Fernando Calvo,1,2,* Romana Ranftl,2 Steven Hooper,1 Aaron J. Farrugia,2 EmadMoeendarbary,3,4 Andreas Bruckbauer,5
Facundo Batista,5 Guillaume Charras,3,6 and Erik Sahai1,*
1Tumour Cell Biology Laboratory, Francis Crick Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY, UK
2Tumour Microenvironment Team, Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW2 6JB, UK
3London Centre for Nanotechnology, University College London, London WC1H 0AH, UK
4Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
5Lymphocyte Interaction Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY, UK
6Department of Cell and Developmental Biology, University College London, London WC1E 6BT, UK
*Correspondence: fernando.calvo@icr.ac.uk (F.C.), erik.sahai@crick.ac.uk (E.S.)
http://dx.doi.org/10.1016/j.celrep.2015.11.052
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Cancer-associated fibroblasts (CAFs) are non-can-
cerous cells found in solid tumors that remodel the tu-
mor matrix and promote cancer invasion and angio-
genesis. Here, we demonstrate that Cdc42EP3/
BORG2 is required for the matrix remodeling, inva-
sion, angiogenesis, and tumor-growth-promoting
abilities of CAFs. Cdc42EP3 functions by coordi-
nating the actin and septin networks. Furthermore,
depletion of SEPT2 has similar effects to those of
loss of Cdc42EP3, indicating a role for the septin
network in the tumor stroma. Cdc42EP3 is upregu-
lated early in fibroblast activation and precedes the
emergence of the highly contractile phenotype char-
acteristic of CAFs. Depletion of Cdc42EP3 in normal
fibroblasts prevents their activation by cancer cells.
We propose that Cdc42EP3 sensitizes fibroblasts to
further cues—in particular, those activating actomy-
osin contractility—and thereby enables the genera-
tion of the pathological activated fibroblast state.INTRODUCTION
Non-cancerous cells and matricellular molecules within the
tumor, collectively defined as the tumor microenvironment
(Bhowmick and Moses, 2005; Calvo and Sahai, 2011; Joyce
and Pollard, 2009), participate in many hallmarks of cancer (Ha-
nahan and Coussens, 2012). Cancer-associated fibroblasts
(CAFs) can provide chemical and physical cues that favor tu-
mor aggressiveness and dissemination (Kalluri and Zeisberg,
2006; Karnoub et al., 2007). CAF-dependent matrix remodeling
can lead to the generation of tracks through the extracellular
matrix (ECM) that enable subsequent cancer cell invasion
(Gaggioli et al., 2007). As a result of increased deposition and
remodeling of the ECM by CAFs, most solid tumors are charac-Cell Repterized by elevated cellular and tissue tension, and enhanced
stiffness (DuFort et al., 2011; Levental et al., 2009; Paszek
et al., 2005). These altered physical properties can promote
malignancy by enhancing cancer cell growth, survival, and
migration (DuFort et al., 2011). CAFs also produce soluble fac-
tors that can promote tumorigenesis (O¨hlund et al., 2014).
Thus, targeting CAFs represents a possibility for therapeutic
intervention.
Changes in the actin cytoskeleton, including increased actin
stress fibers, aSMA expression, and stronger focal adhesions,
is a feature of CAFs (Calvo et al., 2013; Kalluri and Zeisberg,
2006; O¨hlund et al., 2014; Sandbo et al., 2011; Xing et al.,
2010). Increased actomyosin contractility also leads to activa-
tion of the transcriptional regulator YAP1 that is critical for
the CAF phenotype (Calvo et al., 2013). Much less is known
about alterations to other cytoskeletal networks. Septins
are a large conserved family of GTP-binding proteins that
participate in cell division, cytoskeletal organization, vesicular
transport, cell polarity, and membrane remodeling (Mostowy
and Cossart, 2012; Weirich et al., 2008). SEPT2, SEPT6, and
SEPT7 can assemble into hetero-oligomeric complexes and
higher-order structures, including filaments and rings (Sirajud-
din et al., 2007). The adaptor protein Anillin (ANLN) con-
trols actin-septin coordination during cytokinesis, whereas
unknown factors mediate this process during interphase (Ki-
noshita et al., 2002). BORG family proteins, such as Cdc42EP3
and Cdc42EP5, are potential candidates to fulfill this role.
These proteins bind active Cdc42 (Bahou et al., 1992; Joberty
et al., 1999) and SEPT2, 6, and 7 (Joberty et al., 2001). Overex-
pression of Cdc42EP3 in fibroblasts can induce the formation
of pseudopodia and F-actin-containing structures (Hirsch
et al., 2001), while Cdc42EP5 can regulate septin organization
within the cell (Joberty et al., 2001; Sheffield et al., 2003).
However, the role of BORG proteins in the tumor microenviron-
ment is not well understood. Here, we examine the role of
Cdc42EP3/BORG2 and septins in regulating CAF emergence,
maintenance, and functions linked to essential rearrangements
in the actin and septin network.orts 13, 2699–2714, December 29, 2015 ª2015 The Authors 2699
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Figure 1. Identification of Cdc42EP3 as a Key Regulator of CAF Functions
(A) The left panels show images of F-actin (red) and paxillin (green) staining in NF#1, NF#2, CAF#1, and CAF#2. The right panels show images of F-actin (red) and
pS19-MLC2 (green) staining in NF#2 and CAF#2. Scale bars represent 20 mm.
(B) Histograms show focal adhesion (FA) area normalized to total cell area (left graph), an F-actin stress fibers (SF) component (middle graph), and pMLC2
associated to SF (right graph) of NF and CAF cells. Bars represent mean ± SEM. FA measurements, n = 16; measurements were performed on NF#1 and
NF#2 (NF) and CAF#1 and CAF#2 (CAF). F-actin and pMLC2 measurements, n = 12 for NF and n = 15 for CAF; measurements were performed on NF#1 and
CAF#1.
(legend continued on next page)
2700 Cell Reports 13, 2699–2714, December 29, 2015 ª2015 The Authors
RESULTS
Identification of Cdc42EP3 as a Regulator of CAF
Functions
To learn about the role of the cytoskeleton in CAFs, we com-
pared its organization in normal fibroblasts (NFs) and CAFs
from the MMTV-PyMT mammary tumor model (Calvo et al.,
2013). In NFs, F-actin wasmainly at the cell cortex and only small
focal adhesions were present (Figure 1A; quantification in Fig-
ure 1B). In contrast, CAFs had enhanced F-actin stress fibers
containing active pS19 myosin light chain 2 (MLC2; phosphory-
lation on S19 is the major positive regulatory mechanism of
myosin activity in non-muscle cells) and abundant paxillin-posi-
tive focal adhesions (Figure 1A; quantification in Figure 1B). We
confirmed the elevated levels of pS19-MLC2 in CAFs by western
blotting (Figure 1C) and also observed elevated levels of active
Src-family kinases and increased phosphorylation of paxillin on
the FAK and Src-family kinase site, Y118 (Figure 1C) (Deakin
and Turner, 2008).
We selected 21 cytoskeletal components that are highly ex-
pressed in CAFs compared to NFs based on microarray data
(Calvo et al., 2013) and depleted them in CAFs. Following small
interfering RNA (siRNA) transfection, the ability of CAF#1 to con-
tract collagen gels and promote the invasion of breast cancer
cells in ‘‘organotypic’’ assays was determined. Invasion assays
were also performed using CAF#2. Figure 1D shows the effect
of gene depletion in each assay, together with a combinedmetric
of ‘‘CAF functionality’’ derived by averaging the individual assay
results. Depletion ofCdc42ep3 reducedCAF function to a similar
extent as targeting Rock1 (Figure 1D), a known regulator of CAF
function that was used as a positive control (Gaggioli et al.,
2007). Depletion of Cdc42EP3 with three independent siRNA
led to reduced ECM remodeling by CAFs (Figures 1E and 1F,
confirmed in CAF#2; Figure S1A). There was also a significant
reduction in the cancer cell invasion promoting abilities of
CAF#1 and CAF#2 after Cdc42EP3 depletion (Figures 1G and
S1A). Similar results were obtained in human-patient-derived
CAFs (Figures S1B–S1D). Depletion of Cdc42EP3 did not affect
the expression of the CAF markers aSMA and FAP (Figure S1E).
Cdc42ep3 encodes a protein of the BORG family of Cdc42 ef-
fectors (Joberty et al., 1999). We confirmed that Cdc42EP3
levels were upregulated in three different CAFs when compared
to NFs (Figure 1H), whereas levels of other BORGmembers were
unchanged (Figures 1H and S1F). Analysis of expression levels(C) Western blot showing pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-ML
and CAF#3). A tubulin blot is also shown.
(D) RNAi-based loss-of-function screen in CAFs. The indicated genes (left column
evaluated in gel contraction (CAF#1) and organotypic invasion assays (CAF#1 a
transfected CAFs for each experiment (red is low; blue is high). Genes are ranke
(E) Western blot and quantification showing Cdc42EP3 and tubulin expression
(siCEP3). Bars represent mean ± SEM (n = 4).
(F) Histogram shows gel contraction by CAF#1 following transfection with contr
(n = 3).
(G) Images and quantification of 4T1 invasion when co-cultured with CAF#1 tran
mean ± SEM (n = 14 organotypic assays assessed over three experiments). Sca
(H)Western blots showingCdc42EP3, Cdc42EP5, and 14-3-3 levels in three sets o
fold expression (normalized to 14-3-3).
See also Figure S1.
Cell Repof BORG genes in patient datasets (Finak et al., 2008; Karnoub
et al., 2007) revealed that CDC42EP3 was consistently upregu-
lated in the stromal compartment of human breast carcinoma
compared to normal tissue samples (Figure S1G). These ana-
lyses led us to focus on Cdc42EP3 in CAFs.
Altered Septin Networks Are a Feature of CAFs
BORG proteins can regulate the actin and septin cytoskeleton
(Joberty et al., 1999, 2001). We therefore investigated the septin
network in NFs and CAFs. SEPT2 and SEPT7 formed more
extensive networks in CAFs (Figure 2A; quantification in Fig-
ure S2A) that generally co-aligned with actin stress fibers (Fig-
ure S2B). This was confirmed using a biochemical method based
on fractionation of detergent insoluble cytoskeletal components
(Posern et al., 2002). In NFs the amount of actin present in the
insoluble fraction was low (Figures 2B and S2C). This increased
greatly in all four CAFs examined. Importantly, there was a
similar shift of both SEPT2 and SEPT7 into the insoluble fraction
in CAF#1–4 (Figures 2B and S2C). Time-lapse imaging of CAFs
revealed that SEPT2 was highly dynamic, with SEPT2 puncta
moving on and off actin stress fibers (Figure S2D; Movie S1). In
contrast, SEPT2 localization and dynamics did not show a clear
relationship to actin in NFs (Figure S2D; Movie S2). This was re-
flected in the lower co-localization coefficient of the Lifeact and
SEPT2-GFP probes in NFs (Figures S2E and S2F demonstrate
that GFP does not co-localize with F-actin). Structured illumina-
tion microscopy (SIM) revealed that SEPT2-GFP was present
along actin stress fibers, but not always exactly coincident with
them (Figure 2C, white arrows). Furthermore, there were wavy
filaments that occasionally connected nearby stress fibers (Fig-
ure 2C, green arrows). We hypothesized that Cdc42EP3may co-
ordinate the actin and septin networks. Endogenous Cdc42EP3
partially co-localized with actin stress fibers in CAFs (Figure 2D).
Further, SIM revealed that Cdc42EP3-GFP forms an intricate
filamentous network in CAFs (Figure 2E). Similar to the SEPT2
network, the Cdc42EP3 network is clearly aligned with, but not
exactly coincident with, F-actin (Figure 2E). It often formed fila-
ments close to, or wrapped around, actin stress fibers (Figure 2E,
white arrows), while other filaments presented a wavy pattern
and did not co-align with F-actin (Figure 2E, yellow arrows).
Time-lapse imaging showed that Cdc42EP3 moved both be-
tween and along stress fibers, in a manner similar to SEPT2
(Movies S3 and S4). Triple labeling of F-actin, SEPT2-Cherry,
and Cdc42EP3-GFP revealed that Cdc42EP3 co-localized withC2 (pMLC2) in three sets of NF and CAFs (NF#1, NF#2, NF#3, CAF#1, CAF#2,
) were knocked down by smart-pool siRNA, and the functional outcomes were
nd CAF#2). The values indicate the fold activity normalized to control siRNA-
d on their average score (right column).
in CAF#1 after transfection with control and three different Cdc42EP3 siRNA
ol or three different Cdc42EP3 siRNA (siCEP3). Bars represent mean ± SEM
sfected with control or three single Cdc42EP3 siRNA (siCEP3). Bars represent
le bar, 50 mm.
f NF andCAFs (NF#1–3, CAF#1–3). The chart showsCdc42EP3 andCdc42EP5
orts 13, 2699–2714, December 29, 2015 ª2015 The Authors 2701
AB C
D E
F G
Figure 2. CAFs Have Enhanced Actin and Septin Cytoskeletal Networks
(A) Panels show SEPT2 (green) and SEPT7 (red) staining in NF#1 and CAF#1. Zoom areas are shown for each channel and cell type. Scale bars represent 10 mm.
See Figure S2A for quantification.
(B) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2, and SEPT7 in two NF lines (NF#1-2) and four CAF lines (CAF#1-4). A 14-3-3 blot is
also shown as an internal cytosolic control. See Figure S2C for quantification.
(C) Representative SIM images of SEPT2-GFP (yellow) and F-actin (magenta) staining in CAF#1. White arrows indicate SEPT2-GFP filaments along actin stress
fibers. The green arrows indicate SEPT2-GFP filaments connecting nearby stress fibers. Scale bars represent 1 mm.
(D) Panels show actin (red), endogenous Cdc42EP3 (green), and DAPI (blue) staining of CAF#1. Cells were fixed usingmethanol. Zoom-up area showing actin and
Cdc42EP3 is shown. Bar represents 10 mm.
(legend continued on next page)
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SEPT2 filaments (Figure 2F). These filaments exhibited a partial
overlap with F-actin stress fibers (Figure 2F, white arrows), but
also formed connections between actin fibers (Figure 2F, yellow
arrows). Further, SIM imaging revealed that Cdc42EP3 could
localize between F-actin fibers and SEPT2 filaments (Figure 2G).
Together, these data suggest that Cdc42EP3 links the actin and
septin networks.
Depletion of Cdc42EP3 in CAFs resulted in the loss of actin
stress fibers and reduced pS19-MLC2 staining (Figure 3A; quan-
tification in Figure S3A). Moreover, the network of SEPT2 and
SEPT7 fibers was also disrupted upon Cdc42EP3 depletion (Fig-
ure 3B; quantification in Figure S3B, confirmed with two siRNA
in Figure S3C). Fractionation confirmed significant reductions
in filamentous insoluble levels of F-actin, SEPT2, and SEPT7 in
Cdc42EP3-depleted CAFs (Figures 3C and S3D); the total levels
of actin, SEPT2, and SEPT7 were unaltered (Figure S3E). These
changes were associated with significantly reduced CAF cellular
stiffness (Figure 3D).
Gain-of-function experiments demonstrated that overexpres-
sion of Cdc42EP3 in NFs was sufficient to induce actin, SEPT2,
and SEPT7 polymerization (Figure 3E). The ability of Cdc42EP3
to bind both septins (Joberty et al., 1999, 2001) and the data in
Figure S3I showing a direct interaction with F-actin suggest that
it may act as a ‘‘molecular glue’’ linking the two networks. To
explore this idea, we generated Cdc42EP3 mutants defective
in interaction with septins, F-actin, or Cdc42 (Figures S3F–
S3H). We mutated key residues in the septin-binding BD3
domain (Cdc42EP3 GPS-AAA mutant [Joberty et al., 1999,
2001]) and the CRIB domain (Cdc42EP3 IS-AA mutant) (Fig-
ure S3G). To generate a putative actin-binding defective mutant,
we mutated the amino acids KLP in positions 139–141 (Fig-
ure S3H). These residues are within a region of the protein
with high homology to the actin bundling region of ANLN (Field
and Alberts, 1995) and the actin-binding head piece of villin
(Friederich et al., 1992). Immunoprecipitation analyses indicated
that the GPS mutant of Cdc42EP3 still interacted with actin
but had reduced binding to SEPT2 (Figure S3J). On the other
hand, Cdc42EP3 KLP-AAA did not interact with actin but main-
tained the SEPT2 and SEPT7 binding abilities. Unfortunately,
the CRIB domain mutant of Cdc42EP3 (Cdc42EP3 IS-AA) was
also defective in interaction with actin; because it did not repre-
sent a specific loss of function, we excluded this mutant from
further analysis.
We assessed the function of these Cdc42EP3 mutants in
NFs, which have low Cdc42EP3 expression and relatively low
F-actin and filamentous septin levels (Figures 2A and S2B).
Overexpression of wild-type Cdc42EP3 led to prominent
SEPT2 and SEPT7 filaments (Figure 3F with quantification in
Figure 3H) and actin stress fibers (Figures 3G and 3H). As pre-(E) Representative SIM image of F-actin (magenta) and Cdc42EP3-GFP (green) in
associated to actin stress fibers. Yellow arrows indicate Cdc42EP3-GFP wavy fi
(F) Single channel and merged confocal images of SEPT2-Cherry (red), Cdc42EP
Cdc42EP3-containing filaments that co-align with F-actin. Yellow arrows indicate
Scale bar represents 1 mm.
(G) Representative single channel and merged SIM images of SEPT2-Cherry (re
1 mm.
See also Figure S2 and Movies S1, S2, S3, and S4.
Cell Repviously observed in CAFs (Figure 2E), wild-type Cdc42EP3-
GFP in NFs formed filamentous structures that co-aligned
with septin filaments and actin fibers (Figures 3F and 3G, with
quantification in Figure 3H). Neither the GPS nor KLP mutant
of Cdc42EP3 could induce the formation of actin or septin fibers
(Figures 3F–3H). Further, the localization of both mutants was
largely diffuse. These results indicate that Cdc42EP3 needs to
directly bind both F-actin and septins to drive both networks
into a filamentous state.
The Septin Cytoskeleton Is Required for CAF Functions
To test the role of septins in CAFs, we disrupted the septin
network using siRNA-targeting SEPT2. Depletion of SEPT2
led to a loss of actomyosin stress fibers (Figure 4A) and fewer
paxillin-containing focal adhesions (Figure 4B). This pheno-
type was very similar to that observed following Cdc42EP3
depletion or DIAPH1&3 depletion, which is known to block
stress fiber formation (Narumiya et al., 2009). Western blotting
for pS19-MLC2, active Src-family kinases, and pY118-paxillin
confirmed the altered state of the actomyosin cytoskeleton
and focal adhesions (Figure 4C). Biochemical fractionation re-
vealed that depletion of either SEPT2 or SEPT7 led to a signif-
icant reduction in the level of F-actin in CAFs (Figure 4D).
These data establish the inter-relationship of these two net-
works in CAFs. Next, we investigated the functional impor-
tance of the septin network in CAFs. Figure 4E shows that
depletion of SEPT2 or SEPT7 significantly reduced the ability
of CAF#1 to contract collagen-rich gels (confirmed in other
CAFs in Figure S4A). The requirement for both Cdc42EP3
and SEPT2 for effective ECM remodeling was confirmed by
staining for the deposition of fibrillar fibronectin and quantifi-
cation of DQ-collagen I proteolysis (Figures S4B and S4C).
Figure 4F further shows that the reduced ECM remodeling
was associated with lower matrix stiffness. Moreover, the abil-
ity of CAFs to promote cancer cell invasion was reduced
following SEPT2 or SEPT7 depletion (Figure 4G; confirmed in
other CAFs in Figure S4D).
Next, we sought to test the role of Cdc42EP3 and septins
in vivo. CAFs were injected in Matrigel plugs, and matrix re-
modeling was assessed after 7 days. Control siRNA-trans-
fected CAFs organized collagen into thick bundles that
could be visualized by second harmonic imaging and gener-
ated elastin fibers that could be detected by their auto-
fluorescent properties (Figure S4E). Depletion of either
Cdc42EP3 or SEPT2 greatly reduced the formation of thick
collagen bundles and elastin fibers in vivo (Figures 4H and
S4F). These data establish that Cdc42EP3 and septins are
important for the matrix remodeling and invasion-promoting
abilities of CAFs.CAF#1. Bar represents 1 mm.White arrows indicate Cdc42EP3-GFP filaments
laments that do not co-align with F-actin.
3-GFP (green), and F-actin (blue) in CAF#1. White arrows indicate SEPT2- and
SEPT2- and Cdc42EP3-containing filaments that interconnect F-actin cables.
d), Cdc42EP3-GFP (green), and F-actin (blue) in CAF#1. Scale bars represent
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Figure 3. Cdc42EP3 Regulates the Actin and Septin Fibrillar Networks
(A) Images show pS19-MLC2 (green), F-actin (red), and DAPI (blue) staining of CAF#1 following control and Cdc42EP3 siRNA (siCEP3, smart pool). The grayscale
panels show individual channel magnifications of the indicated areas. Scale bars, 25 mm. See Figure S3A for quantification.
(B) Images show SEPT2 (green), SEPT7 (red), and DAPI (blue) staining of CAF#1 following control and Cdc42EP3 siRNA (siCEP3, smart pool). The grayscale
panels show individual channel magnifications of the indicated areas. Scale bars, 25 mm. See Figure S3B for quantification.
(legend continued on next page)
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CAFs Require Cdc42EP3 and SEPT2 to Promote
Angiogenesis and Tumor Growth
We hypothesized that Cdc42EP3 might also be required for
other functions of CAFs besides matrix remodeling. In particular,
we focused on angiogenesis and tumor growth. qRT-PCR anal-
ysis revealed that Cdc42EP3 is required in CAFs for the expres-
sion of the key angiogenic factor, Vegfa, and several other genes
implicated in angiogenesis, including Vegfc, Tgfb1, and Tgfb2
(Figures 5A and S5A). The expression of other factors involved
in tumor-stroma crosstalk was not changed following Cdc42EP3
depletion, or in the case of Vegfb, Tgfb3, and Ccl2, modestly
increased (Figure S5A). Consistent with the qRT-PCR data,
secreted VEGF-A was reduced in CAFs depleted of Cdc42EP3
or SEPT2 (Figure 5B). We tested the ability of CAFs to drive
angiogenesis in vivo. Fibroblasts were injected in Matrigel plugs
and the extent of angiogenesis evaluated a week later by endo-
mucin staining. Depletion of Cdc42EP3 or SEPT2 dramatically
reduced the angiogenic potential of CAFs in vivo (Figures 5C
and 5D). To test whether the defective matrix remodeling and
angiogenic activity of CAFs lacking Cdc42EP3 might influence
tumor growth, we established CAFs that were stably depleted
for Cdc42EP3 using two different small hairpin RNA (shRNA) se-
quences (Figure S5B). These CAFs, or the appropriate control
CAFs, were then ‘‘admixed’’ with PyMT breast cancer cells
and injected orthotopically in immune-competent FVBmice. Fig-
ure 5E shows that tumors containing Cdc42EP3-depleted CAFs
were smaller than those tumors with control CAFs. Depletion of
Cdc42EP3 in CAFswas also associated with longer survival (Fig-
ure 5F). Histological analysis revealed that aSMA-positive cells
were visible in both control and Cdc42EP3-depleted tumors
(Figure 5G). More interestingly, tumors containing Cdc42EP3-
depleted CAFs tended to grow as a viable rim surrounding a
necrotic core (visible in the lower magnification images in Fig-
ure 5H). This was correlated with reduced blood vessel density
in the interior of the tumors, although similar numbers of vessels
were present at the margins.
Cdc42EP3 Is Required for Mechano-transduction and
YAP Activation
Cdc42EP3 and SEPT2 are important for regulation of the acto-
myosin cytoskeleton and paxillin phosphorylation (Figures 4A–
4C). As these events are responsive to themechanical properties
of the substratum (DuFort et al., 2011), we hypothesized that
Cdc42EP3 and septins may be required for responses to(C) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2
pool). A 14-3-3 blot is also shown as a cytosolic control. See Figure S3D for qua
(D) Box and whisker plot showing the Young’s elastic modulus of CAF#1 cells with
the lower to upper quartiles; the middle line represents the mean. The horizont
surements for siCtr; n = 53 single measurements for siCEP3).
(E) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2,
NF#1. The histogram shows the F/G ratios of actin, SEPT2, and SEPT7. Bars rep
(F) Top left inserts show GFP (green), SEPT2 (blue), and SEPT7 (red) staining of NF
The grayscale panels show individual channel magnifications of perinuclear area
(G) Top left inserts show GFP (green) and actin (red) staining of NF#1 following tra
panels show individual channel magnifications of perinuclear areas. Scale bars,
(H) Histograms show fibrillar SEPT2&7 area (top) and F-actin stress fiber (SF)
mean ± SEM (5 < n < 10 single-cell measurements).
See also Figure S3.
Cell Repchanges in matrix stiffness. Figure 6A shows that GFP-SEPT2
forms fibrillar structures within the cell body in CAFs plated on
relatively stiff 12 kPa substrates (Figure 2). However, when the
same CAFs are plated on a soft 500 Pa substrate, the distribu-
tion of SEPT2 was cortical and fibrillar structures were absent.
NFs fail to form SEPT2 fibers in the cell body on both 500 Pa
and 12 kPa substrates (Figure 6A). Further, we noted that the
localization of Cdc42EP3 in CAFs changed depending on sub-
strate stiffness: it was diffuse on soft substrates and formed
fibrillar structures on stiff matrices (Figure S6). These data
demonstrate that septin network organization changes in res-
ponse to substrate stiffness in CAFs, which express high levels
of Cdc42EP3.
To test if Cdc42EP3 was causally implicated in the cytoskel-
etal changes, we undertook a series of gain- and loss-of-function
experiments. We observed that, in contrast to control NFs, NFs
overexpressing Cdc42EP3 had increased actin stress fibers and
focal adhesions on 12 kPa substrates (Figure 6B). We addition-
ally investigated the activity of the mechano-responsive tran-
scriptional co-activator YAP (Calvo et al., 2013; Dupont et al.,
2011). Figure 6C shows that Cdc42EP3 overexpression in-
creases the nuclear localization of YAP (quantification in Fig-
ure 6D) and leads to a dose-dependent increase in the mRNA
levels of two YAP target genes in NFs, Ctgf, and Ankrd1 (Fig-
ure 6E). CAFs are highly mechano-responsive; they have few
stress fibers or focal adhesions and cytoplasmic YAP on
500 Pa matrices, but on 12 kPa matrices, they have nuclear
YAP and form extensive stress fibers and paxillin-containing
focal adhesions. In the absence of Cdc42EP3 or SEPT2, these
mechano-induced changes do not occur (Figures 6F–6H). We
confirmed the reduction in YAP transcriptional activation by
measuring Ankrd1 and Ctgf mRNA (Figures 6I). Together, these
data show that Cdc42EP3 and the septin network are required
for CAFs to respond to changes in matrix stiffness and activation
of the mechano-responsive transcriptional regulator YAP.
Cdc42EP3 Is Induced and Required Early in Fibroblast
Activation
To explore the chronology of Cdc42EP3 upregulation during the
transition from NF to CAF, we evaluated different stages of
MMTV-PyMT tumor progression (Calvo et al., 2013). Cdc42EP3
expression is already enhanced in hyperplasia-associated fibro-
blasts (HpAF) and maintained in adenoma-associated fibro-
blasts (AdAFs) and CAFs (Figures 7A and 7B). In agreement,, and SEPT7 in CAF#1 following control and Cdc42EP3 siRNA (siCEP3, smart
ntification.
control and Cdc42EP3 siRNA (siCEP3, smart pool). The central box represents
al line extends from the minimum to the maximum value (n = 61 single mea-
and SEPT7 in empty vector () and Flag-Cdc42EP3 (Flag-CEP3)-transfected
resent mean ± SEM (n = 3).
#1 following transfection with GFP or GFP-tagged Cdc42EP3 (CEP3) proteins.
s. Scale bars, 20 mm.
nsfection with GFP or GFP-tagged Cdc42EP3 (CEP3) proteins. The grayscale
20 mm.
component (bottom) for the indicated experimental points. Bars represent
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Figure 4. The Septin Cytoskeleton Is Required for CAF Functions
(A) Images showing F-actin (red), pS19-MLC2 (green), and DAPI (blue) staining of CAF#1 following control, Cdc42EP3, SEPT2, and DIAPH1&3 siRNA transfection
(smart pools). Scale bars, 20 mm. Histograms show an F-actin stress fiber (SF) component and pMLC2 associated to SF for the indicated points. Bars represent
mean ± SEM (12 < n < 15).
(B) Images show F-actin (red), paxillin (green), and DAPI (blue) staining of CAF#1 following with control, Cdc42EP3, SEPT2, and DIAPH1&3 siRNA transfection
(smart pools). Scale bars, 20 mm. The histogram shows the focal adhesion (FA) area normalized to total cell area in single cells. Bars represent mean ± SEM (10 <
n < 12).
(legend continued on next page)
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increased levels of F-actin and insoluble filamentous septins
were also evident in HpAFs and AdAFs (Figure 7C), as well as
Src and paxillin phosphorylation (Figure 7D). Interestingly,
Cdc42EP3 expression and cytoskeletal rearrangements pre-
ceded the strong activation of MLC2 in AdAFs and CAFs.
Similarly, YAP activation, as determined by the expression of
YAP target genes Cyr61, Amotl2, Ankrd1, and Ctgf, was only
observed in AdAFs and CAFs (Figure 7E). These data indicate
that increased Cdc42EP3 expression is an early event that pre-
cedes the highly contractile phenotype and activation of YAP
in CAFs.
Many factors, including HGF, TGFb, and SDF-1a, were able to
induceCdc42ep3mRNA in NFs. TGFb andmurine breast cancer
cell (4T1) conditioned media (CM) yielded the greatest induction
of Cdc42EP3 protein expression (Figures 7F and S7A). Consis-
tently, treatment of NFs with either TGFb or 4T1 CM for 48 hr trig-
gered F-actin and septin rearrangements (Figures S7B and S7C),
and phosphorylation of MLC2, Src-family kinases, and paxillin
(Figure 7F). Furthermore, depletion of Cdc42EP3 prevented
conditioned media from causing changes in the F/G ratios of
actin and SEPT2, or in MLC2 and Src activation (Figures 7G
and 7H). Gain-of-function experiments in NFs demonstrated
that increasing the levels of Cdc42EP3 expression enhanced
the ability of TGFb and 4T1 CM to induce Src activation and
elevated basal pS19-MLC2 levels (Figures S7D and S7E). These
changes were associated with increasedmatrix remodeling after
TGFb- and 4T1 CM treatments (Figure S7F). Further, if contrac-
tility was boosted by overexpressing MLC2, as occurs in CAFs
(Calvo et al., 2013), then a synergistic increase in matrix remod-
eling was observed in cells with high Cdc42EP3 levels (Fig-
ure S7G). These data suggest that elevated expression of
Cdc42EP3 sensitizes cells to functional activation by the con-
tractile cytoskeleton. We therefore tested whether elevated
Cdc42EP3 levels were required for functional activation of NFs.
Depletion of Cdc42EP3 prevented both the activation of collagen
gel contraction and cancer cell invasion by NFs in response to
cancer cell conditioned media (Figures 7I and 7J). Together,
these data demonstrate that Cdc42EP3 is critical for the func-
tional activation of normal fibroblasts by cancer cells.
DISCUSSION
Here, we describe Cdc42EP3 as a key regulator of the conver-
sion of normal fibroblasts into CAFs. CAFs have enhanced stress
fibers, aSMA-positive fibers, and focal adhesions (Calvo et al.,
2013; Kalluri and Zeisberg, 2006; O¨hlund et al., 2014; Sandbo(C) Western blot showing phosphorylated levels of pY118-paxillin (pPax), pY41
control, Cdc42EP3 (CEP3), DIAPH1&3, and SEPT2 siRNA (smart pools). Cdc42E
(D)Western blots showing fibrillar (F) and soluble (G) actin and SEPT2 in CAF#1 fol
pools). The histogram shows the F/G ratios of actin and SEPT2. Bars represent
(E) Histogram shows gel contraction by CAF#1 following control, SEPT2, and SE
(F) Histogram shows the elastic modulus of matrices remodeled by NF#1 or CAF
mean ± SD (n = 167 single measurements for NF-siCtr; n = 142 for CAF-siCtr; n
(G) Quantification of 4T1 invasion when co-cultured with CAF#1 transfected with
(n = 9 organotypic assays assessed over two experiments).
(H) Charts show second harmonic generation (SHG) of collagen fibers and elastin
(CEP3), and SEPT2 siRNA. Line and error bars indicate mean ± SEM (n = 4 plug
See also Figure S4.
Cell Repet al., 2011; Xing et al., 2010). We now describe that CAFs are
also characterized by increased levels of filamentous septins.
These filaments are partly aligned with F-actin fibers in CAFs
(Dolat et al., 2014; Joberty et al., 2001; Kinoshita et al., 1997).
However, septin filaments and actin fibers do not precisely co-
localize and time-lapse imaging indicated that the actin and
septin networks exhibit different dynamic behaviors. During
cytokinesis, the adaptor protein ANLN plays a key role in linking
the actin and septin networks (Kinoshita et al., 2002), although
recent work suggests that septins alone may be sufficient to
drive formation of actin ring-like structures (Mavrakis et al.,
2014). Our analyses indicate that Cdc42EP3 may play a similar
role during interphase in CAFs. Cdc42EP3 can bind both
actin and septins and localizes between F-actin fibers and
SEPT2 filaments. Dynamic and mutational analysis suggests
that Cdc42EP3 can bind to septins independent of binding to
F-actin. We propose that dynamic septin filaments associated
with Cdc42EP3 are then able to interact with actin filaments.
Cdc42EP3 overexpression in NFs induces F-actin and septin
polymerization, suggesting that connectivity between the two
networks stabilizes themboth. Indeed, the ‘‘cross brace’’ pattern
of SEPT2 and Cdc42EP3 localization between stress fibers
could provide mechanical support for the contractile actin cyto-
skeleton. This may allow for increased isometric tension in the
F-actin network. These cytoskeletal changes are significant for
both remodeling of the extracellular environment within tumors
and cell signaling within CAFs, such as YAP activation. In the
absence of Cdc42EP3, CAFs are unable to effectively remodel
the ECM, leading to a reduction in matrix stiffness and less can-
cer cell invasion. In vivo analysis confirms the importance of
Cdc42EP3 for ECM remodeling, as measured by collagen’s
second harmonic generation and elastin autofluorescence, and
reveals that Cdc42EP3 is required for CAFs to promote angio-
genesis. Similar loss-of-function phenotypes are observed
when the septin network is depleted. Further, in vivo ‘‘admix’’ ex-
periments with breast cancer cells demonstrate that Cdc42EP3
is required for efficient tumor growth. Our data establish that
connectivity between the actin and septin networks is crucial
for the function of CAFs from breast and squamous cell carci-
noma. It will be interesting to determine the role of actin and sep-
tin networks in CAFs from pancreatic cancer, which can have
both tumor-promoting and suppressive effects (O¨zdemir et al.,
2014; Rhim et al., 2014).
Intriguingly, Cdc42EP3 upregulation precedes the emergence
of highly contractile CAFs and YAP activation. Cdc42EP3 ex-
pression is already elevated in fibroblasts at the hyperplasia6-Src (pSFK), and pS19-MLC2 (pMLC2) in CAF#1 following transfection with
P3 and tubulin blots are also shown.
lowing control, Cdc42EP3 (CEP3), SEPT2, SEPT7, and DIAPH1&3 siRNA (smart
mean ± SEM (n = 5).
PT7 siRNA (smart pools). Bars represent mean ± SEM (n = 8).
#1 following control, Cdc42EP3, or SEPT2 siRNA (smart pools). Bars indicate
= 173 for CAF-siCEP3; n = 51 for siSEPT2).
control or SEPT2 and SEPT7 siRNA (smart pool). Bars represent mean ± SEM
-positive areas in the CAF#1 matrix plugs transfected with control, Cdc42EP3
s from different mice).
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Figure 5. Cdc42EP3 Is Required for the Pro-tumorigenic Activity of CAFs In Vivo
(A) mRNA levels of angiogenic factors Vegfa, Vegfc, and Tgfb1 in NF#1 and CAF#1 following transfection with control and Cdc42EP3 siRNA (CEP3, smart pool).
Bars represent mean ± SEM (n = 12).
(B) Secreted levels of VEGF-A on CAF#1 following transfection with control, Cdc42EP3 (CEP3), SEPT2, or SEPT7 siRNA (smart pool). Bars represent mean ±SEM
(n = 6).
(C) Representative images showing endomucin and vimentin staining of matrix plugs with NF#1 or CAF#1 transfectedwith control, Cdc42EP3 (CEP3), and SEPT2
siRNA (smart pools) and injected sub-cut in mice. Scale bars, 100 mm.
(D) Chart shows quantification of endomucin staining relative to fibroblast number (vimentin staining). Line and error bars indicate mean ± SEM (n = 7, except for
CAF#1-siCtr that n = 9 and CAF#1-siSEPT2 that n = 5; each experimental point is an individual plug from a different mouse).
(legend continued on next page)
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stage. Multiple signaling pathways converge upon Cdc42EP3
promoter (Esnault et al., 2014; Gomis et al., 2006; McGee
et al., 2011; Zhao et al., 2008). Therefore, Cdc42EP3 expression
may be highly responsive to the small perturbations in tissue
homeostasis that are likely to occur in hyperplastic tissue. How-
ever, this raises the question of why its expression does not lead
to fully activated fibroblasts early in disease progression. It has
been argued that both chemical and mechanical stimulation
are needed for the acquisition of pathological active fibroblasts
(Hinz, 2007). We propose that Cdc42EP3 is located at a node
linking both activating processes. Soluble factors—either from
hyperplastic epithelia or leukocytes infiltrating the pre-malignant
tissue—could induce Cdc42EP3 expression in normal fibro-
blasts. This would sensitize the cells to mechanical cues, but in
the absence of changes to the physical environment it would
not trigger the activation of mechano-responsive signaling path-
ways. This is consistent with the small effect of Cdc42EP3 over-
expression alone on NF function and the synergy observed when
Cdc42EP3 and MLC2 are both overexpressed (Figure S7G).
Further, when CAFs are grown on low stiffness gels (500 Pa,
slightly above normal mouse mammary tissue stiffness) they
do not form stress fibers or large focal adhesions and have
only modest levels of nuclear YAP (Figures 6E–6G). Full activa-
tion of the highly contractile CAF phenotype and YAP activation
would require concomitant stiffening of the ECM. The changes in
the physical properties of the ECM are likely to happen with slow
kinetics and may not coincide with the faster upregulation of
Cdc42EP3 induced by soluble factors. This would explain why
full pathological activation of fibroblasts does not occur early in
disease progression (Calvo et al., 2013).
To conclude, we demonstrate a key role for coordination be-
tween the actin and the septin networks in CAFs. This is required
for force-mediated matrix remodeling, promoting cancer cell in-
vasion, angiogenesis, and tumor growth. Further, if coordination
of F-actin and septin networks is prevented, then fibroblasts
are unable to activate mechano-sensing signaling pathways,
including paxillin phosphorylation, Src, and YAP. The elevated
expression of Cdc42EP3 in the stroma of pre-malignant lesions
enables the subsequent activation of these pathways and the
emergence of fully activated CAFs.
EXPERIMENTAL PROCEDURES
cDNA, siRNA, and Reagents
Murine Cdc42EP3 cDNA was acquired from Thermo Scientific (pCMV-Sport
6-Cdc42EP3) and subcloned into pEGFP.C1 and PKR5.1-Flag. pEGFP-
Cdc42EP3 was used to generate Cdc42EP3(IS-AA), Cdc42EP3(GPS-AAA),
and Cdc42EP3(KLP-AAA) and was subcloned in pCSII-IRES to generate sta-(E) Box and whisker plot showing volumes of orthotopic tumors generated by co
expressing control or two different shRNA targeting Cdc42EP3. The central box re
the horizontal line extends from the minimum to the maximum value (n = 7, exce
(F) Survival curves for orthotopic tumors generated by co-injection of TS1 murine
different shRNA targeting Cdc42EP3. The survival curve represents the percentag
estimated by the Kaplan-Meier method and compared among subsets using the
(G) Representative images of orthotopic tumors generated by co-injection of TS1
or two different shRNA targeting Cdc42EP3 and stained for H&E or aSMA. Scale
(H) Representative images of orthotopic tumors generated by co-injection of TS1
or two different shRNA targeting Cdc42EP3 and stained for H&E or endomucin.
See also Figure S5.
Cell Repble cells lines. pEGFP-MLC2 was a gift fromMichael Olson (Beatson Institute).
SEPT2-GFP and SEPT2-Cherry were a gift from Elias Spiliotis (Drexel Univer-
sity). MARS-Lifeact was a gift from Michael Sixt (Institute of Science
and Technology). siRNA were purchased from Dharmacon and are listed in
the Table S1. shRNA-targeting murine Cdc42EP3 were purchased from
Thermo Scientific (pGIPZ backbone). The following growth factors and
drugs were used: TGFb (Peprotech), LPA (Sigma), HGF (Peprotech), and
SDF-1 (Peprotech). Breast cancer cell conditioned medium was harvested
from 4T1 cells in DMEM 1% fetal bovine serum (FBS) for 48 hr and filtered
through a 0.22-mm filter. Fibroblasts were transfected with 100 nM siRNA
using DharmaFECT 1 (Dharmacon) and Lipofectamine (Life Technologies) for
plasmids.
Cell Lines
Fibroblasts from normal mammary glands (NFs), hyperplastic mammary tissue
(HpAFs), mammary adenoma/early carcinoma tissue (AdAFs), and mammary
carcinoma (CAFs) have been previously described (Calvo et al., 2013). Fibro-
blasts were cultured in DMEM (Invitrogen), 10% FBS, and 1% insulin-sele-
nium-transferrin (ITS). 4T1 murine breast cancer cells were used for the
organotypic invasion assays and to generate breast cancer cell conditioned
media. SCC12 human squamous cell carcinoma cells were used for organo-
ytpic invasion assays of HN-CAF and Cer-CAF. MMTV-PyMT TS1 murine
breast cancer cells were used to generate orthotopic tumors in syngeneic
FVB/n mice. Cell lines stably expressing Cdc42EP3-GFP, shRNA control,
and shRNA-targeting murine Cdc42EP3 were generated by lentiviral infection.
NF#1 stably expressing Cdc42EP3-GFP were sorted into low (NF#1-
Cdc42EP3-GFPlow) and high (NF#1-Cdc42EP3-GFPhigh) expression by fluo-
rescence-activated cell sorting.
ECM Remodeling and Invasion Assays
ECM-remodeling (contraction) assays and human SCCCAF and mouse mam-
mary CAFs organotypic culture systems were as previously described (Calvo
et al., 2013). Details are provided in the Supplemental Experimental
Procedures.
Screening
Smart-pool siRNA were transiently transfected into two individual CAF lines
(CAF#1 and CAF#2). The functional role of each gene was assessed using
collagen gel contraction assays and 4T1 breast cancer cell organotypic inva-
sion assays. Each experimental point was normalized against the control
siRNA for that experiment.
Biophysical Methods
AFMwas performed as described (Calvo et al., 2013), and details are provided
in the Supplemental Experimental Procedures. Polyacrylamide gels of defined
elastic moduli were made as described (Yeung et al., 2005).
Immunofluorescence
Cells were fixed in 4% paraformaldehyde, except for the analysis of endoge-
nous septins when cells were fixed in ice-cold methanol for 10 min. Cells
were permeabilized by incubation in PBS 0.5% NP-40 (Sigma) at 4C for
20 min (twice), PBS 0.3% Triton 100 (Sigma) at room temperature (RT) for
20 min, and PBS 0.1% Triton 100 at room temperature (RT) for 15 min (twice).
Samples were blocked in 4% BSA PBS 0.05% Tween20 (Sigma) and-injection of TS1 murine MMTV-PyMT breast cancer cells with CAF#3 stably
presents the lower to upper quartiles; the middle line represents the mean; and
pt for CAF-shCtr that n = 6). Tumors were measured at day 24 post-injection.
MMTV-PyMT breast cancer cells with CAF#3 stably expressing control or two
e of animals alive at the indicated time point after injection. Survival curveswere
log rank test.
murine MMTV-PyMT breast cancer cells with CAF#3 stably expressing control
bar, 500 mm.
murine MMTV-PyMT breast cancer cells with CAF#3 stably expressing control
Scale bar, 200 mm.
orts 13, 2699–2714, December 29, 2015 ª2015 The Authors 2709
****
500 Pa 12 kPa
YA
P
 n
uc
le
ar
/c
yt
os
ol
ic
 ra
tio
A
****
Fo
ld
 e
xp
re
ss
io
n
Ankrd1 Ctgf
DC YAP
Cdc42EP3
H
siC
tr
siC
EP
3
siS
EP
T2 siC
tr
siC
EP
3
siS
EP
T2
0.0
0.5
1.0
1.5
2.0
2.5
3.0
500 Pa 12 kPa
** **s
iC
tr
si
C
dc
42
EP
3
500 Pa 12 kPa
F-actin paxillin
si
S
E
P
T2
F-actin YAPG
YA
P
 n
uc
le
ar
/c
yt
os
ol
ic
 ra
tio
NF
 si
Ct
r
CA
F s
iC
tr
CA
F s
iC
EP
3
CA
F s
iYA
P
0
2000
4000
6000
8000
10000
*** ** *** **
R
el
at
iv
e 
m
R
N
A
 le
ve
ls500 Pa 12 kPa
500 Pa 12 kPa
si
C
tr
si
C
dc
42
EP
3
500 Pa 12 kPa
si
S
E
P
T2
500 Pa 12 kPa
500 Pa 12 kPa
**
I
Ankrd1 Ctgf
*
***
NF#1
aPk21aP005
SEPT2-GFP F-actin                Merge SEPT2-GFP F-actin                Merge
N
F#
1
C
A
F#
1
NF#1
B F-actin
pPax (insert GFP)
N
F#
1 
12
 k
Pa
Fo
ld
 e
xp
re
ss
io
n
CEP3CEP3
- -
GFP-CAAX
Cdc42EP3-GFP
N
F#
1 
12
 k
Pa
E
CAF#1F
Figure 6. Cdc42EP3 Is Required for Mechano-sensing
(A) Images show single and merged channels of SEPT2-GFP (yellow) and F-actin (magenta) staining of NF#1 and CAF#1 when seeded on soft (500 Pa) and stiff
(12 kPa) matrices. Scale bar represents 10 mm.
(B) Images show F-actin (red) and pY118-Paxillin (pPax) staining of NF#1 when seeded on stiff (12 kPa) matrices following transfection with GFP-CAAX and
Cdc42EP3-GFP. Inserts show GFP signal (grayscale). Scale bar represents 10 mm.
(legend continued on next page)
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incubated with primary antibody in blocking solution overnight at 4C. After
three PBS washes, secondary antibody in blocking solution was added for
3 hr. After three PBS washes, samples were mounted and analyzed using an
inverted Zeiss LSM780/Leica SP8. For analysis of fibronectin production, cells
were kept in 1% FBS for 24 hr before fixing and were permeabilized for only
5 min in 0.1% Triton 100 at RT during the staining procedure to reduce detec-
tion of intracellular protein. Antibody description and working dilutions can be
found in Table S2. Time-lapse microscopy was performed using a Zeiss
LSM780 with cells in CO2-independent media (GIBCO) containing 10% FBS.
The details of the imaging analysis methods are provided in the Supplemental
Experimental Procedures.
Structured Illumination Microscopy
Cells were processed for immunostaining as usual and mounted in a 1:1
mixture of glycerol and MOWIOL. Imaging was performed using a Zeiss
ELYRA PS1 and data processed using the SIM tools in the Zen 2011 software.
Channel alignment was performed with 0.1-mmTetraSpeck fluorescent micro-
spheres (Life Technologies).
Collagenase Activity Measurements
A thin layer of collagen gel (4.6 mg/ml) containing 50 mg/ml of DQFITC-Collagen
I from bovine skin (Life Technologies) and 10% FBS was generated. After 1 hr,
fibroblasts were seeded on top. After 48 hr, samples were fixed in 4% parafor-
maldehyde for 1 hr and stained for F-actin. A fluorescein isothiocyanate signal
generated by cleaved collagen and F-actin staining was detected using an in-
verted Leica SP8 microscope.
F-G Actin and Septin Fractionation
We determined the relative proportions of filamentous and globular actin
and septins by sedimentation, followed by quantitative analysis by SDS-
PAGE. Cells were lysed in warm F-actin stabilization buffer (PIPES
100 mM [pH 6.9], 5 mM MgCl2, 1 mM EGTA, 30% glycerol, 0.1% Triton
X-100, 0.1% NP-40, 0.1% Tween-20, 0.15% 2-mercaptoethanol, 1 mM
ATP, and complete EDTA-free cocktail) and homogenized using a 25G
gauge. Lysates were incubated for 10 min at 37C, and cellular debris
was removed by centrifugation at room temperature. Supernatants were
then subjected to ultracentrifugation at 37C (1 hr at 100,000 g). Superna-
tants containing the globular cytosolic fraction (G fraction) were removed.
Using a similar volume of 10 mM CaCl2 10 mM Cytochalasin D, the pellet
containing the fibrillar fraction (F fraction) was dissolved for 1 hr in ice.
Both G and F fractions were mixed with 53 sample buffer before western
blot analysis. Antibody description and working dilutions can be found in
Table S2.
In Vitro F-actin Binding Assay
Human platelet actin (Cytoskeleton, Actin Binding Protein Biochem Kit
#BK013) in general actin buffer (5 mM Tris-HCl [pH 8.0] and 0.2 mM CaCl2,
supplemented with 0.2 mM ATP) was polymerized using actin polymerization
buffer (50 mM KCl, 2 mM MgCl2, and 1 mM ATP) at 24
C for 1 hr. 0.3 mM
GST-Cdc42EP3 (Abcam, ab161060) and recombinant 0.3 mM glutathione(C) Images show GFP (green) and YAP (red) staining of NF#1 when seeded st
represents 10 mm.
(D) Histogram shows nuclear YAP fluorescent intensity/cytoplasmic YAP fluoresce
following transfection with GFP-CAAX or Cdc42EP3-GFP. The mean and 95% c
(E) Fold mRNA levels of YAP target genes Ankrd1 and Ctgf in stable cell lines NF#
6 hr. Bars represent mean ± SEM (n = 5).
(F) Images show F-actin (red) and paxillin (green) staining of CAF#1when seeded o
Cdc42EP3, or SEPT2 siRNA (smart pools). Scale bar represents 10 mm.
(G) Images show F-actin (red) and YAP (green) staining of CAF#1 when seeded on
Cdc42EP3, or SEPT2 siRNA (smart pools). Scale bar is 10 mm.
(H) Histogram shows nuclear YAP fluorescent intensity/cytoplasmic YAP fluoresce
are shown (23 < n < 80 cells).
(I) Relative mRNA levels of YAP target genes Ankrd1 and Ctgf in NF#1 and CAF#1
pools). Bars represent mean ± SEM (n = 6).
See also Figure S6.
Cell RepS-transferase (GST) (Sigma-Aldrich; SRP5348) were incubated with 20 mM
F-actin for 1 hr at 24C and centrifuged at 150,000 g for 90 min at 24C. Equal
volumes of the supernatant and pellet fractions were resolved using a 4%–
12% SDS-PAGE gel, stained with InstantBlue (Expedeon) for actin staining,
and further processed by western blotting (for GST and GST-Cdc42EP3)
analysis.
Immunoprecipitation
GFP-Cdc42EP3 immunoprecipitations were performed in HEK293 cells. Cells
were transiently transfected and subsequently lysed in NP-40 lysis buffer
(50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, and 1% NP-40). Lysates
were cleared by centrifugation and supernatants were further cleared by
pre-incubating with 25 ml of G-sepharose. Cleared supernatants were then
mixed with 2 mg of anti-GFP antibody plus 25 ml of G-sepharose and incubated
for 2 hr at 4C. Immunoprecipitations were then washed four times with NP-40
washing buffer (50mMTris [pH 7.4], 150mMNaCl, 1mMEDTA, 1%NP40, and
0.25% gelatin) before adding sample buffer. Antibody details can be found in
Table S2.
Western Blotting
Unless stated otherwise, all protein lysates were obtained from cells seeded
on top of a thin layer of a mixture of collagen I:Matrigel matrices. Western
blot exposures within the dynamic range were obtained on film and quantified
by densitometry with the program NIH Image 1.60, except for Figures S1B,
S3I, and S7D, which were generated with the Azure c300 scanner. Antibody
details can be found in Table S2.
Detection of VEGF-A in Conditioned Media
ELISA was used to assess the levels of secreted murine VEGF-A in accor-
dance with the manufacturers’ instructions (R&D; Mouse VEGF DY493-05).
105 cells were seeded on 12-well plates, and 24 hr later cells were washed
and 0.6 ml of DMEM supplemented with 0.5% FBS added to each well. Me-
dium was collected and assayed after 24 hr of conditioning.
In Vivo Matrigel Plugs
2 3 106 fibroblasts were suspended in 100 ml of PBS and mixed in 300 ml of
Matrigel. Then 300 ml of the mixture were injected subcutaneously on the
mammary fat pad of a 12-week-old FVB/n female. After 7 days, the plugs
were fixed in 4% paraformaldehyde. Blood vessel density was calculated
by normalizing the area of endomucin staining to the area of vimentin stain-
ing of all the slices processed. Antibody details are in Table S2. Collagen
second harmonic generation (SHG) and elastin signal were acquired by
excitation of sections with an 880-nm pulsed Ti-Sapphire laser and emitted
light acquired at 440 nm (SHG) and 535 nm (Elastin) using a Leica SP8
microscope.
Generation of Syngeneic Orthotopic Tumors
MMTV-PyMTTS1murine breast cancer cells were used to generate orthotopic
tumors in wild-type FBV/n mice. 106 TS1 cells and 33 106 CAFs (shRNA con-
trol, shRNA-Cdc42EP3#1, or shRNA-Cdc42EP3#2) were suspended in 100 mliff (12 kPa) matrices following transfection with Cdc42EP3-GFP. Scale bar
nt intensity of NF#1when seeded on soft (500 Pa) and stiff (12 kPa)matrices
onfidence interval are shown (23 < n < 80 cells).
1 null, NF#1-Cdc42EP3low, and NF#1-Cdc42EP3high maintained in 1% FBS for
n soft (500 Pa) and stiff (12 kPa) matrices following transfection with control,
soft (500 Pa) and stiff (12 kPa) matrices following transfection with control,
nt intensity for the indicated conditions. Themean and 95%confidence interval
following transfection with control, Cdc42EP3 (CEP3), and YAP siRNA (smart
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Figure 7. Cdc42EP3 Is Induced and
Required Early in Fibroblast Activation
(A) Western blots of Cdc42EP3 in fibroblasts iso-
lated from different disease stages (NF, HpAF,
AdAF, and CAF).
(B) Relative levels of Cdc42ep3 mRNA in fibro-
blasts from different disease stages. Bars indicate
mean ± SEM (n = 4).
(C) Western blot showing the fibrillar (F) and solu-
ble (G) actin, SEPT2, and SEPT7 in fibroblasts from
different disease stages. A 14-3-3 blot is also
shown as an internal cytosolic control.
(D) Western blots showing pY118-paxillin (pPax),
pY416-Src (pSFK), and pS19-MLC2 (pMLC2) and
tubulin levels in fibroblasts isolated from different
disease stages.
(E) GSEA-derived heatmap showing the relative
levels of mRNA expression of YAP target genes
(Cyr61, Amotl2, Ankrd1, and Ctgf) in fibroblasts
isolated from different disease stages on dupli-
cate. Colors range from dark red to dark blue,
representing, respectively, the highest and lowest
normalized expression of the gene.
(F) Western blots showing pY118-paxillin (pPax),
pY416-Src (pSFK), and pS19-MLC2 (pMLC2) in
NF#1 subjected to 1% FBS (NM), TGFb (2 ng/ml),
and breast cancer cell conditioned media (CM) for
48 hr. Cdc42EP3 and actin blots are also shown.
(G) Western blots of fibrillar (F) and soluble (G)
fractions of actin and SEPT2 in NF#1 subjected to
1% FBS (NM) or breast cancer cell conditioned
media (CM) following transfection with control and
two single Cdc42EP3 (CEP3) siRNA.
(H) Western blots showing tubulin and pY118-
paxillin (pPax), pY416-Src (pSFK), and pS19-
MLC2 (pMLC2) in NF#1 subjected to 1% FBS (NM)
or breast cancer cell conditioned media (CM)
following transfection with control and two single
Cdc42EP3 (CEP3) siRNA.
(I) Histogram showing gel contraction of NF#1
subjected to normal media (NM) or breast cancer
cell conditioned media (CM) following transfection
with control and two single Cdc42EP3 (CEP3)
siRNA. Bars represent mean ± SEM (n = 5).
(J) Histogram showing organotypic cancer cell in-
vasion of NF#1 subjected to normal media (NM) or
breast cancer cell conditionedmedia (CM) following
transfection with control two single Cdc42EP3
(CEP3) siRNA. Bars represent mean ± SEM (n = 5).
See also Figure S7.of PBS:Matrigel (50:50) and injected orthotopically into the mammary fat pad
of 6- to 8-week-old females. To calculate tumor volume, the formula V = (length
3 width2)/2 was used. Tumors were fixed in 4% paraformaldehyde for histo-
logical analysis. Antibody description and working dilutions can be found in
Table S2. Mice were kept in accordance with UK regulations under project li-
cense PPL 70/ 8380.
mRNA Analysis
RNAwas isolated usinganRNeasyKit (QIAGEN).Reverse transcriptionwasper-
formed using Precision nanoScript 2 Reverse-Transcription Kit (PrimerDesign),
and qPCR was performed using PrecisionPLUS 2x qPCR MasterMix with ROX
and SybrGreen (PrimerDesign). Oligonucleotides for qRT-PCR are described
in the Table S3. Expression levels are normalized to the expression of Gapdh,
Rplp1, or Lamc2. Gene-set enrichment analyses (GSEA) details are provided
in the Supplemental Experimental Procedures.2712 Cell Reports 13, 2699–2714, December 29, 2015 ª2015 The AuAnalysis of Expression in Clinical Samples
mRNA levels of BORG family members in the stromal compartment of human
tumors were obtained from GSE9014 (Finak breast dataset) and GSE8977
(Karnoub breast dataset) (Finak et al., 2008; Karnoub et al., 2007). Probes
on the Finak dataset were A_23_P166453 (CDC42EP1), A_23_P1602
(CDC42EP2), A_23_P209636 (CDC42EP3), A_23_P66891 (CDC42EP4), and
A_24_P44916 (CDC42EP5). Probes on the Karnoub dataset were 204693_at
(CDC42EP1), 214014_at (CDC42EP2), 225685_at (CDC42EP3), 218062_x_at
(CDC42EP4), and 227850_x_at (CDC42EP5).
Statistical Analyses
Paired or unpaired two-tailed Student’s t test, Mann-Whitney’s test, and one-
way ANOVA with Tukey post-test (for multiple comparisons) were performed
using GraphPad Prism (GraphPad Software). Unless stated otherwise, mean
values and SEM are shown. Survival curves were estimated based on thethors
Kaplan-Meier method and compared using a log rank test. p values of less
than 0.05 are considered statistically significant: *, p < 0.05; **, p < 0.01; ***,
p < 0.001; ****, p < 0.0001; ns, non-significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, three tables, and four movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2015.11.052.
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Supplemental Experimental Procedures 
ECM-remodeling assays 
To assess force-mediated matrix remodeling, 75 × 103 fibroblasts were embedded in 
100 µL of a mixture of Collagen I (BD Biosciences) and Matrigel (BD Biosciences) 
yielding a final collagen concentration of ~4.6 mg/mL and a final Matrigel concentration 
of ~2.2 mg/mL (Collagen I:Matrigel matrix hereafter) and seeded on a 35 mm glass 
bottom MatTek dish (MatTek Co.). Once the gel was set, cells were maintained in 
DMEM + 10% FBS (unless otherwise stated) + 1% ITS. Unless stated otherwise, the gel 
contraction value refers to the contraction observed after 3 days. To obtain the gel 
contraction value, the relative diameter of the well and the gel were measured using 
ImageJ software, and the percentage of contraction was calculated using the formula 
100 × (well diameter – gel diameter) / well diameter.  
Invasion assays 
The invasion index was calculated by measuring the total area over which breast cancer 
cells had dispersed (including invading and non-invading cells) and the area of non-
invading cells. The value shown is the average of the measurement (1 – [non-invading 
area/total area]) of at least ten measurements from two or more independent 
experiments and the error bars represent the SEM. MATLAB script was used to 
automatically identify the total cell area and the non-invading area. The M files are 
available on request, email robert.jenkins@crick.ac.uk 
Atomic Force Microscopy (AFM) 
In brief, to assess the elastic modulus of gels remodeled by fibroblasts, 75 × 103 
fibroblasts were embedded in 100 µL of Collagen I:Matrigel and seeded on ultra-low 
attachment 96 well plate well (Costar). Once the gels were set, they were maintained in 
DMEM + 10% FCS + 1% ITS. After 3 days, the elastic modulus of the gels was 
measured. On the day of the experiment, the gels were gently lifted from their well and 
fixed in the center of 50 mm glass bottom petri dishes (Fluorodish) using cyanoacrylate 
superglue. After 5 min, Leibovitz L-15 medium (Invitrogen) supplemented with 10% FCS 
was added to the dish. To assess the elastic modulus of the different fibroblasts, 75 × 
103 cells were seeded into 50 mm glass bottom petri dishes in DMEM + 10% FCS + 1% 
ITS. After 2 days, their elastic modulus was measured. AFM measurements were 
   
performed using a JPK Nanowizard-I (JPK instruments) interfaced to an inverted optical 
microscope (IX-81, Olympus). AFM cantilevers with pyramidal tips (MLCT) and nominal 
spring constants of 0.07 Nm-1 were modified by gluing beads to the cantilever underside 
with UV curing glue. 35 μm radius glass beads and 7.5 μm radius latex beads 
(Invitrogen) were used for indentation experiments on gels and cells respectively. 
Cantilever spring constants were determined prior to modification using the thermal 
noise method implemented in the AFM software (JPK SPM). Prior to any indentation 
tests, the sensitivity of the cantilever was set by measuring the slope of force-distance 
curves acquired on glass regions of the petri dish. For indentation experiments on gels 
the optical microscope was used to align the tip of the cantilever over regions in the 
middle of the gel and, for each gel, measurements were acquired in 30-40 locations 
~100 μm apart. For AFM measurements on cells the tip of the cantilever was aligned 
over regions on top of the cell nucleus and measurements were acquired in two 
locations a few microns apart. Force-distance curves were acquired with an approach 
speed of 5 µm.s-1 until reaching the maximum set force of 3 nN and 2 nN for gels and 
cells, respectively. After the experiment, the elastic moduli were extracted from the 
force-distance curves by fitting the contact portion of curves to a Hertz contact model. 
For each force-distance curve, goodness of fit was evaluated by calculating 𝑟2 values 
and only fits with 𝑟2 >0.80 were retained for further analyses (representing on average 
80% of the acquired force-curves). The calculated values for elasticities are presented 
as mean value and standard deviation (Mean±SD). 
Gene-set enrichment analysis (GSEA) 
Data files containing the array data of the NF, HpAF, AdAF and CAF progression series 
are available at the NCBI Gene Expression Omnibus (GEO) under GSE45256. Array 
data was processed and analyzed using the Gene-set enrichment analysis software, 
developed by the Broad Institute of MIT and Harvard (USA) and available at 
www.broadinstitute.org, following the program guidelines. The specific settings applied 
in all analyses are: Number of Permutations (1000), Permutation Type (Gene set), 
Enrichment statistic (Weighted), Metric for ranking genes (t Test). The rest of the fields 
were left as defaulted. Gene sets were sourced from the Broad Institute database. 
   
GSEA was used to interrogate the expression data on the expression of YAP target 
genes (Cyr61, Amotl2, Ankrd1 and Ctgf) to generate a heat map of expression. 
Image analysis 
Unless stated otherwise, image analysis was performed with Volocity (PerkinElmer). 
Spearman and Persons correlations were used to measure co-localization coefficients. 
To measure ‘F-actin Stress Fiber Component’ and ‘Association of pMLC2 to Stress 
Fibers’, ‘non-cortical’ and ‘cortical’ F-actin/pMLC2 intensities of individual cells were 
calculated and divided to generate a ratio of ‘non-cortical’ vs ‘cortical’ intensities that 
was used in the plots. To determine ‘non-cortical’ and ‘cortical’ regions, firstly the total 
area of the cell was delimited using F-actin staining, and total F-actin and pMLC2 
intensities calculated after thresholding to reduce background signal. Total area was 
then cropped in to exclude the ‘cortical’ region, and the ‘non-cortical’ F-actin and pMLC2 
intensities calculated. ‘Cortical’ F-actin and pMLC2 intensities were then calculated by 
subtracting the ‘non-cortical’ values from the total. To measure SEPT2 and SEPT7 
fibrillar content, single cell SEPT2 and SEPT7 staining was thresholded to eliminate 
cytosolic background signal and the intersect of the resulting SEPT2 and SEPT7 areas 
used as the ‘Fibrillar Septin Area’. To quantify focal adhesions, paxillin staining was 
thresholded to eliminate background signal and the resulting paxillin-positive area 
calculated. Plots represent the ratio of the paxillin-positive area to the total cellular area 
(determined by F-actin staining). To quantify YAP localization, a measure of its 
activation, nuclear YAP intensity (determined by the intensity within the region delimited 
by DAPI staining) and cytosolic YAP intensity (determined by the intensity without the 
region delimited by DAPI staining and within the region delimited by F-actin staining) 
were calculated. Plots represent the ratio of nuclear versus cytosolic YAP.  To calculate 
the collagenase activity of CAFs, the mean intensity of FITC signal generated by 
cleaved DQFITC-Col was calculated for each field of view containing an individual cell. 
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Figure S1. Identification of Cdc42EP3 as a key regulator of CAF functions, related to Figure 1. (A) 
Quantification of gel contraction (left) and 4T1 organotypic invasion (right) of CAF#2 following transfection with 
control or three single Cdc42EP3 (CEP3) siRNA. Bars represent mean ± SEM (n=2 for gel contraction; n=10 
organotypic assays assessed over 3 experiments). (B) Western blot showing Cdc42EP3 and tubulin expression 
in human CAFs from head-and-neck (HN-CAF) and cervical (Cer-CAF) carcinomas after transfection with control 
and 3 different Cdc42EP3 siRNA (siCEP3). (C) Histograms show gel contraction by HN-CAF and Cer-CAF 
following transfection with control or Cdc42EP3 siRNA (siCEP3#3). Bars represent mean ± SEM (n=7). (D) 
Representative images and quantification of SCC12 organotypic invasion of HN-CAF and Cer-CAF after 
transfection with control or Cdc42EP3 siRNAs. Bars represent mean ± SEM (n=5 organotypic assays assessed 
in one experiment). Scale bar, 100μm. (E) Representative Western blots showing αSMA, FAP, FSP1 and tubulin 
expression in CAF#1 following transfection with control or Cdc42EP3 siRNA (smart-pool). (F) Relative mRNA 
expression of BORG genes Cdc42ep1 (Cep1), Cdc42ep2 (Cep2), Cdc42ep3 (Cep3), Cdc42ep4 (Cep4) and 
Cdc42ep5 (Cep5) in fibroblasts from normal murine mammary glands (NFs) and from MMTV-PyMT mammary 
carcinomas (CAFs). Bars represent the mean ± SEM of 4 different sets of NF (NF#1-4) and CAFs (CAF#1-4) 
performed on duplicate. (G) Box-and-whisker plots showing the relative expression of BORG genes CDC42EP1 
(CEP1), CDC42EP2 (CEP2), CDC42EP3 (CEP3), CDC42EP4 (CEP4) and CDC42EP5 (CEP5) in the stromal 
compartment of normal mammary glands or breast carcinoma in human disease. Plots were generated by 
interrogating the Finak Breast Dataset GSE9014 and Karnoub Breast Dataset GSE8977. The central box 
represents values from the lower to upper quartile. The middle line represents the mean. The horizontal line 
extends from the minimum to the maximum value.  
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Supplementary Figure 2. CAFs have enhanced actin and septin cytoskeletal networks, related to Figure 
2. (A) From Figure 2A. Histogram shows quantification of fibrillar SEPT2&7 in NF#1 and CAF#1. Bars represent 
mean ± SEM (n=5 for NF#1 and n=12 for CAF#1). (B) Representative images of NF#1 and CAF#1 fixed in 4% 
PFA and stained for F-actin (red) and SEPT2 (green). Indicated zoom up areas are shown in greyscale for each 
channel and cell type. Bars are 20μm. (C) From Figure 2B. Histograms show the F/G ratios of actin, SEPT2 and 
SEPT7. Bars represent mean ± SEM (n=6 for actin and SEPT2, n=4 for SEPT7). (D) Panels show stills from 
time-lapse movies S1 and S2 of SEPT2-GFP and MARS-Lifeact in NF#1 and CAF#1. (E) Histogram shows 
Spearman correlation co-efficient of co-localization of SEPT2-GFP and MARS-Lifeact signal in NF#1 and CAF#1. 
Bars represent mean ± SEM (n=10 cells). (F) Histogram shows Spearman correlation co-efficient of co-
localization of GFP signal and F-actin in CAF#1 transfected with GFP or SEPT2-GFP. Line and error bars 
indicate mean ± SEM (n=12).  
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Figure S3. Cdc42EP3 regulates the actin and septin fibrillar networks, related to Figure 3. (A) From Figure 
3A. Histograms show: Pearson correlation co-efficient of co-localization of pMLC2 and F-actin (left panel), F-actin 
stress fibers component (middle panel) and pMLC2 associated to stress fibers (right panel) of CAF#1 cells 
following transfection with control or Cdc42EP3 siRNA (siCEP3, smart-pool). Bars represent mean ± SEM (n=10 
single cell measurements). (B) From Figure 3B. Histogram shows fibrillar SEPT2&7 of CAF#1 cells following 
transfection with control or Cdc42EP3 siRNA (siCEP3, smart-pool). Bars represent mean ± SEM (n=23 single 
cell measurements). (C) Representative images of CAF#1 transfected with control or two independent 
Cdc42EP3 siRNA, fixed in 4% PFA and stained for F-actin (red), SEPT2 (green) and SEPT7 (red). Bars are 
20μm. (D) From Figure 3C. Histogram shows the F/G ratios of actin, SEPT2 and SEPT7 of CAF#1 following 
transfection with control and Cdc42EP3 siRNA (siCEP3 smart-pool). Bars represent mean ± SEM (n=7). (E) 
Representative Western blots showing actin, SEPT2 and SEPT7 expression in CAF#1 following transfection with 
control or Cdc42EP3 siRNA (smart-pool). (F) Diagram showing the different domains and functional regions in 
murine Cdc42EP3 (254 aa). (G) Sequence alignments of Cdc42EP2, Cdc42EP3, Cdc42EP5, Cdc42EP4 and 
Cdc42EP1 in the N-terminal regions (containing the CRIB domain and Borg Homology Domain 1/BHD1), and 
BHD3 domain regions. Conserved residues are highlighted in black. Mutated residues in the Cdc42EP3 mutants 
IS-AA and GPS-AAA are highlighted in yellow. (H) Alignments of Cdc42EP3 with ANLN and Villin showing the 
putative actin-binding region present in Cdc42EP3 but absent in Cdc42EP5. Conserved residues are highlighted 
in black, whereas semi-conserved residues are in two different degrees of grey. Mutated residues in the 
Cdc42EP3 mutant KLP-AAA are highlighted in yellow. (I) Coomassie-stained gel (actin) and western blots (anti-
GST) showing equal volumes of supernatant (S) and pellet (P) fractions from high-speed sedimentation of pre-
polymerized actin filaments in the presence of recombinant GST-Cdc42EP3 or GST. (J) Western blots show anti-
GFP co-immune-precipitation of actin and SEPT2 with over-expressed GFP or Cdc42EP3-GFP proteins in 
HEK293 cells. Wild-type (wt), and Cdc42EP3 (CEP3) mutants IS-AA, GPS-AAA and KLP-AAA are shown. Graph 
represents quantification of the blots indicating the amount of Actin and SEPT2 bound to Cdc42EP3 mutants 
relative to Cdc42EP3 wild-type.  
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Figure S4. The septin cytoskeleton is required for CAF functions., related to Figure 4. (A) Histogram shows 
gel contraction by CAF#2 (blue), CAF#3 (green) and CAF#4 (red) following transfection with control, Cdc42EP3 
(CEP3), SEPT2 and SEPT7 siRNA. Every experiment is shown individually. Lines represent mean of all cell 
lines. (B) Images show merged channels of fibronectin (FN, green), F-actin (red) and DAPI (blue) staining of 
NF#1 and CAF#1 following transfection with control, Cdc42EP3 (siCEP3) and SEPT2 siRNAs (smart-pools). (C) 
Images show merged channels of cleaved collagen (DQFITC-Col, yellow) and F-actin (red) staining of NF#1 and 
CAF#1 following transfection with control, Cdc42EP3 (CEP3) and SEPT2 siRNAs (smart-pools). Histogram 
shows DQFITC-Col fluorescence area per single cell of the indicated experimental points. Line and error bars 
indicate mean ± SEM (n=27 individual cells). (D) Quantification of 4T1 invasion when co-cultured with CAF#3 
(green) and CAF#4 (red) following transfection with control, Cdc42EP3 (CEP3), SEPT2 and SEPT7 siRNA. Bars 
represent mean ± SEM (n=4). (E) Emission spectral un-mixing of CAF matrix plugs. Chart shows normalized 
intensity of emitted light at the indicated wavelengths of CAF matrix plug samples after excitation with an 880 nm 
pulsed Ti–Sapphire laser. Peak at 440nm corresponds to the second harmonic generation (SHG) signal from 
collagen fibers and the second peak comes from elastin autofluorescence. (F) Panels show second harmonic 
generation (SHG) of collagen fibers (red) and elastin autofluorescent signal (green) of CAF#1 matrix plugs 
transfected with control, Cdc42EP3 (CEP3) and SEPT2 siRNA (smart-pools). Each channel is also shown 
individually in greyscale. Scale bar, 30μm.  
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Figure S5. Cdc42EP3 is required for the pro-tumorigenic activity of CAFs in vivo, related to Figure 5. (A) 
Relative mRNA levels of angiogenic factors (Vegfb, Sdf1/Cxcl12, Fgf2, Angpt1), TGFβ family members (Tgfb2 
and Tgfb3) and immune-modulator (Il1a, Il1b and Il6, Ccl2 and Csf2) in CAF#1 following transfection with control 
and Cdc42EP3 siRNA (CEP3, smart-pool). Bars represent mean ± SEM (n=3). (B) Western blot showing 
Cdc42EP3 and tubulin expression in CAF#3 after stable transfection with control and 2 different Cdc42EP3 
shRNA (shCEP3). 
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Figure S6. Cdc42EP3 is required for mechano-sensing, related to Figure 6. Images show GFP signal 
(greyscale) of Cdc42EP3-GFP-tranfected CAF#1 when seeded on soft (~500 Pa) and stiff (~12 kPa) matrices. 
Scale bar is 50μm.  
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Figure S7. Cdc42EP3 is induced and required early in fibroblast activation, related to Figure 7. (A) Fold 
mRNA expression levels of Cdc42ep3 in NF#1 subjected to 1%FBS, breast cancer cell conditioned media (CM), 
2 ng/mL of TGFβ, 5 ng/mL of HGF or 50 ng/mL SDF-1 for 6 hours. Bars represent mean ± SEM (n=6).  (B) 
Western blots showing fibrillar (F) and soluble (G) actin and SEPT2 levels in NF#1 subjected to 1% FBS, breast 
cancer cell conditioned media (CM) or 2 ng/mL of TGFβ for 3 days. (C) Histogram shows the F/G ratios of actin 
and SEPT2. Bars represent mean ± SEM (n=3). (D) Representative Western blots showing actin, tubulin, GFP 
(CEP3) and phosphorylated levels of pS19-MLC2 (pMLC2), pY118-paxillin (pPax) and pY416-Src (pSFK) in 
stable cell lines NF#1-null, NF#1-Cdc42EP3low and NF#1-Cdc42EP3high following stimulation with 1%FBS, 
2ng/mL TGFβ and breast cancer cell conditioned media (CM) for 16h. (E) Charts show the fold levels of pMLC2, 
pPax and pSFK (n=4). (F) Histogram shows gel contraction by stable cell lines NF#1-null and NF#1-
Cdc42EP3high under stimulation with 1%FBS, 2ng/mL TGFβ and breast cancer cell conditioned media (CM). Bars 
represent mean ± SEM (n=3). (G) Histogram shows the gel contraction of NF#1 following transfection with empty 
vector (null), Cdc42EP3 (CEP3), MLC2 or Cdc42EP3 & MLC2. Bars represent mean ± SEM (n=4). 
   
Supplementary Tables 
Table S1. siRNAs used in this study, related to Experimental Procedures 
 
siRNA Company Cat. No Species 
Cdc42EP3 oligo 1 Dharmacon D-046421-01 Mouse 
Cdc42EP3 oligo 2 Dharmacon D-046421-02 Mouse 
Cdc42EP3 oligo 3 Dharmacon D-046421-03 Mouse 
Cdc42EP3 oligo 4 Dharmacon D-046421-04 Mouse 
ANLN oligo 1 Dharmacon D-056109-01 Mouse 
ANLN oligo 2 Dharmacon D-056109-02 Mouse 
ANLN oligo 3 Dharmacon D-056109-03 Mouse 
ANLN oligo 4 Dharmacon D-056109-04 Mouse 
SEPT2 oligo 1 Dharmacon D-051534-01 Mouse 
SEPT2 oligo 2 Dharmacon D-051534-02 Mouse 
SEPT2 oligo 3 Dharmacon D-051534-03 Mouse 
SEPT2 oligo 4 Dharmacon D-051534-04 Mouse 
SEPT7 oligo 1 Dharmacon D-042160-01 Mouse 
SEPT7 oligo 2 Dharmacon D-042160-02 Mouse 
SEPT7 oligo 3 Dharmacon D-042160-03 Mouse 
SEPT7 oligo 4 Dharmacon D-042160-04 Mouse 
DIAPH3 oligo 1 Dharmacon D-049507-01 Mouse 
DIAPH3 oligo 2 Dharmacon D-049507-02 Mouse 
DIAPH3 oligo 3 Dharmacon D-049507-03 Mouse 
DIAPH3 oligo 4 Dharmacon D-049507-04 Mouse 
TAGLN oligo 1 Dharmacon D-062786-01 Mouse 
TAGLN oligo 2 Dharmacon D-062786-02 Mouse 
TAGLN oligo 3 Dharmacon D-062786-03 Mouse 
TAGLN oligo 4 Dharmacon D-062786-04 Mouse 
THBS1 oligo 1 Dharmacon D-044041-01 Mouse 
THBS1 oligo 2 Dharmacon D-044041-02 Mouse 
THBS1 oligo 3 Dharmacon D-044041-03 Mouse 
THBS1 oligo 4 Dharmacon D-044041-04 Mouse 
DIAPH1 oligo 1 Dharmacon d-064854-05 Mouse 
DIAPH1 oligo 2 Dharmacon d-064854-06 Mouse 
DIAPH1 oligo 3 Dharmacon d-064854-07 Mouse 
DIAPH1 oligo 4 Dharmacon d-064854-08 Mouse 
PDLIM4 oligo 1 Dharmacon D-056154-01 Mouse 
PDLIM4 oligo 2 Dharmacon D-056154-02 Mouse 
PDLIM4 oligo 3 Dharmacon D-056154-03 Mouse 
PDLIM4 oligo 4 Dharmacon D-056154-04 Mouse 
ARHGAP18 oligo 1 Dharmacon D-057063-01 Mouse 
ARHGAP18 oligo 2 Dharmacon D-057063-02 Mouse 
ARHGAP18 oligo 3 Dharmacon D-057063-03 Mouse 
ARHGAP18 oligo 4 Dharmacon D-057063-04 Mouse 
ARHGDIB oligo 1 Dharmacon D-042404-01 Mouse 
ARHGDIB oligo 2 Dharmacon D-042404-02 Mouse 
ARHGDIB oligo 3 Dharmacon D-042404-03 Mouse 
ARHGDIB oligo 4 Dharmacon D-042404-04 Mouse 
SDC3 oligo 1 Dharmacon D-059803-01 Mouse 
SDC3 oligo 2 Dharmacon D-059803-02 Mouse 
SDC3 oligo 3 Dharmacon D-059803-03 Mouse 
SDC3 oligo 4 Dharmacon D-059803-04 Mouse 
SDC1 oligo 1 Dharmacon D-044225-01 Mouse 
SDC1 oligo 2 Dharmacon D-044225-02 Mouse 
SDC1 oligo 3 Dharmacon D-044225-03 Mouse 
SDC1 oligo 4 Dharmacon D-044225-04 Mouse 
   
SDC2 oligo 1 Dharmacon D-046419-01 Mouse 
SDC2 oligo 2 Dharmacon D-046419-02 Mouse 
SDC2 oligo 3 Dharmacon D-046419-03 Mouse 
SDC2 oligo 4 Dharmacon D-046419-04 Mouse 
SDC4  oligo1 Dharmacon D-044221-01 Mouse 
SDC4  oligo2 Dharmacon D-044221-02 Mouse 
SDC4  oligo3 Dharmacon D-044221-03 Mouse 
SDC4  oligo4 Dharmacon D-044221-04 Mouse 
DSTN oligo 1 Dharmacon D-049526-01 Mouse 
DSTN oligo 2 Dharmacon D-049526-02 Mouse 
DSTN oligo 3 Dharmacon D-049526-03 Mouse 
DSTN oligo 4 Dharmacon D-049526-04 Mouse 
NES oligo 1 Dharmacon D-057300-01 Mouse 
NES oligo 2 Dharmacon D-057300-03 Mouse 
NES oligo 3 Dharmacon D-057300-04 Mouse 
NES oligo 4 Dharmacon D-057300-17 Mouse 
SDCBP oligo 1 Dharmacon D-043821-01 Mouse 
SDCBP oligo 2 Dharmacon D-043821-02 Mouse 
SDCBP oligo 3 Dharmacon D-043821-03 Mouse 
SDCBP oligo 4 Dharmacon D-043821-04 Mouse 
TACC1 oligo 1 Dharmacon D-050702-01 Mouse 
TACC1 oligo 2 Dharmacon D-050702-02 Mouse 
TACC1 oligo 3 Dharmacon D-050702-03 Mouse 
TACC1 oligo 4 Dharmacon D-050702-04 Mouse 
AGTR1 oligo 1 Dharmacon D-057103-01 Mouse 
AGTR1 oligo 2 Dharmacon D-057103-02 Mouse 
AGTR1 oligo 3 Dharmacon D-057103-03 Mouse 
AGTR1 oligo 4 Dharmacon D-057103-04 Mouse 
GEF-H1 (AHRGEF2) oligo1 Dharmacon D-040120-01 Mouse 
GEF-H1 (AHRGEF2) oligo2 Dharmacon D-040120-02 Mouse 
GEF-H1 (AHRGEF2) oligo3 Dharmacon D-040120-03 Mouse 
GEF-H1 (AHRGEF2) oligo4 Dharmacon D-040120-04 Mouse 
LARG (ARHGEF12) oligo1 Dharmacon D-041056-01 Mouse 
LARG (ARHGEF12) oligo2 Dharmacon D-041056-02 Mouse 
LARG (ARHGEF12) oligo3 Dharmacon D-041056-03 Mouse 
LARG (ARHGEF12) oligo4 Dharmacon D-041056-04 Mouse 
ROCK1 oligo1 Dharmacon D-046504-01 Mouse 
ROCK1 oligo2 Dharmacon D-046504-02 Mouse 
ROCK1 oligo3 Dharmacon D-046504-03 Mouse 
ROCK1 oligo4 Dharmacon D-046504-04 Mouse 
RHOG oligo1 Dharmacon D-064124-01 Mouse 
RHOG oligo2 Dharmacon D-064124-02 Mouse 
RHOG oligo3 Dharmacon D-064124-03 Mouse 
RHOG oligo4 Dharmacon D-064124-04 Mouse 
Ifi27l2a oligo 1 Dharmacon D-063667-01 Mouse 
Ifi27l2a oligo 2 Dharmacon D-063667-02 Mouse 
Ifi27l2a oligo 3 Dharmacon D-063667-03 Mouse 
Ifi27l2a oligo 4 Dharmacon D-063667-04 Mouse  
Cdc42EP3 oligo 1 Dharmacon D-017358-01 Human 
Cdc42EP3 oligo 2 Dharmacon D-017358-02 Human 
Cdc42EP3 oligo 3 Dharmacon D-017358-03 Human 
Cdc42EP3 oligo 4 Dharmacon D-017358-04 Human 
 
 
 
   
Table S2. Antibodies used in this study, related to Experimental Procedures.  
 
Antibody Company Cat. No Clonal 
Dilution 
IF WB IHC IP 
14-3-3 Santa Cruz 1647 Monoclonal (H8)  1:1000   
Actin Sigma 13853 monoclonal (Clone AC40)  1:1000   
Beta-Tubulin Sigma T7816 
monoclonal 
(clone 
SAP.4G5) 
1:100    
Cdc42EP3 proteintech 10780 polyclonal 1:100 1:500   
Cdc42EP5 Abcam ab75004 polyclonal  1:500   
Endomucin Santa cruz 65495 monoclonal (clone V.7C7)   1:200  
GFP Santa cruz 8334 polyclonal  1:1000  1:200 
GFP Roche 11814460001 
monoclonal 
(clones 7.1 
and 13.1) 
 1:5000  1:200 
GST GE Healthcare 
27-4577-
01 Polyclonal  1:1000   
Paxillin Transduction labs 610051 
monoclonal 
(clone 349) 1:100    
Phalloidin-TRITC Sigma P1951 n/a 1:500    
Phospho-MLC2 (S19) Cell Signaling 3672 polyclonal 1:100 1:1000   
Phospho-Paxilin (Y118) Invitrogen 44-722G Polyclonal  1:1000   
Phospho-Src Family Kinases 
(Y416) Cell Signaling 2101 polyclonal  1:1000   
SEPT2 proteintech 60075 monoclonal  (ag1946) 1:100 1:1000   
SEPT7 proteintech 13818 polyclonal 1:100 1:1000   
Vimentin Sigma V2258 monoclonal (clone LN-6) 1:500  1:250  
YAP Santa cruz 101199 monoclonal (clone 63.7) 1:200 1:2000  1:100 
 
 
 
 
 
 
 
 
 
 
 
   
Table S3. Oligonucleotides used in this study, related to Experimental Procedures.  
 
Target Sequence Target full name species 
Amolt2 
F AACCGCCACCTGGCAAGCAA 
Angiomotin like 2 
mouse 
R GGTCCTCGATGGCACCACGC mouse 
Angpt1 
F CACATAGGGTGCAGCAACCA 
Angiopoietin 1 
mouse 
R CGTCGTGTTCTGGAAGAATGA mouse 
Ankrd1 
F AAACGGACGGCACTCCACCG 
Ankyrin repeat domain 1 
mouse 
R CGCTGTGCTGAGAAGCTTGTCTCT mouse 
Ccl2 
F TTAAAAACCTGGATCGGAACCAA 
Chemokine (C-C motif) ligand 2 
mouse 
R GCATTAGCTTCAGATTTACGGGT mouse 
Cdc42ep1 
F ATGTCTTCGGAGATACGTCCTT 
Cdc42 effector protein 1  (Cdc42EP1) 
mouse 
R GACTCTGCGAACCTGTTGGA mouse 
Cdc42ep2 
F TCCCCATCTATTTGAAACGTGG 
Cdc42 effector protein 2 (Cdc42EP2) 
mouse 
R CCGCTGTTCCTGGAAGGAG mouse 
Cdc42ep3 
F AACACCCTCCCCGGTGCTCAA 
Cdc42 effector protein 3  (Cdc42EP3) 
mouse 
R CTCCCTGGTGGACTGCCCCAT mouse 
Cdc42ep4 
F CAGCTCTGTGAACTCGAAGC 
Cdc42 effector protein 4  (Cdc42EP4) 
mouse 
R GCTAGTGAGGAAAGACGTGTCC mouse 
Cdc42ep5 
F GGGATGCCCACCCTAGAGT 
Cdc42 effector protein 5  (Cdc42EP5) 
mouse 
R TGGAGGTCAGCATTTGAGCAG mouse 
Csf2 
F GGCCTTGGAAGCATGTAGAGG Colony stimulating factor 2 (granulocyte-
macrophage) / GM-CSF 
mouse 
R GGAGAACTCGTTAGAGACGACTT mouse 
Ctgf 
F CCCTGCCCTAGCTGCCTACCG 
Connective tissue growth factor 
mouse 
R GCTTCGCAGGGCCTGACCAT mouse 
Cyr61 
F GCCGTGGGCTGCATTCCTCT 
Cysteine-rich angiogenic induce 61 
mouse 
R GCGGTTCGGTGCCAAAGACAGG mouse 
Fgf2 
F GCGACCCACACGTCAAACTA 
Fibroblast growth factor 2 
mouse 
R TCCCTTGATAGACACAACTCCTC mouse 
Il1a 
F CGAAGACTACAGTTCTGCCATT 
Interleukin 1 alpha 
mouse 
R GACGTTTCAGAGGTTCTCAGAG mouse 
Il1b 
F GAAATGCCACCTTTTGACAGTG 
Interleukin 1 beta 
mouse 
R TGGATGCTCTCATCAGGACAG mouse 
Il6 
F TAGTCCTTCCTACCCCAATTTCC 
Interleukin 6 
mouse 
R TTGGTCCTTAGCCACTCCTTC mouse 
Lamc2 
F ATGGGTCTCCTGCAAAGCTC 
Laminin, gamma 2 
mouse 
R AAAGTAACTCAGCTGGGGGC mouse 
Rplp1 
F ACCGTGCCGGCAGTCTACAG 
Ribosomal Protein Large, P1 
mouse 
R ATGTTGACATTGGCCAGAGCCTTG mouse 
Sdf1 
F TGCATCAGTGACGGTAAACCA 
Chemokine (C-X-C motif) ligand 12 / CXCL12 
mouse 
R TTCTTCAGCCGTGCAACAATC mouse 
   
Tgfb1 
F CTCCCGTGGCTTCTAGTGC 
Transforming growth factor, beta 1 
mouse 
R GCCTTAGTTTGGACAGGATCTG mouse 
Tgfb2 
F TCGACATGGATCAGTTTATGCG 
Transforming growth factor, beta 2 
mouse 
R CCCTGGTACTGTTGTAGATGGA mouse 
Tgfb3 
F CCTGGCCCTGCTGAACTTG 
Transforming growth factor, beta 3 
mouse 
R TTGATGTGGCCGAAGTCCAAC mouse 
Vegfa 
F GCACATAGAGAGAATGAGCTTCC 
Vascular endothelial growth factor A 
mouse 
R CTCCGCTCTGAACAAGGCT mouse 
Vegfc 
F GAGGTCAAGGCTTTTGAAGGC 
Vascular endothelial growth factor C 
mouse 
R CTGTCCTGGTATTGAGGGTGG mouse 
 
 
